News
-
Quanticate Expands Operations In India And Its Commitment To Provide High Quality, Effective Data-Related CRO Services To Support Clinical Trials
5/10/2012
Quanticate, a leading global data-focused clinical research organization (CRO), today announced expansion of its capabilities in India with the opening of a new office in Bangalore, India.
-
Clinical Reference Laboratory Creates Unique Position In South America
4/4/2012
A global leader in the provision of central laboratory services for the clinical trials industry, Clinical Reference Laboratory (CRL), has recently announced the full integration of its Argentina-based partner Laboratorio Hidalgo to its worldwide network of laboratories providing a much desired South American presence.
-
Clinical Reference Laboratory Strengthens Its Position In Asia
3/12/2012
Clinical Reference Laboratory (CRL), a global leader in the provision of central laboratory services for the clinical trials industry, has recently announced the full integration of its long-standing laboratory partner Phoenix Pharma Central Services in Singapore.
-
Celerion And Ricerca Biosciences Announce ‘The Biosimilars Alliance’ To Offer Clients A More Effective Development Path For Biosimilars
3/1/2012
Celerion, the premier provider of innovative early stage drug development solutions, and Ricerca Biosciences, a drug safety assessment expert in harnessing external preclinical innovation, announce the formation of “The Biosimilars Alliance”.
-
Absorption Systems’ Innovation Rewarded With New U.S. Patent For CellPort Technologies
2/22/2012
Absorption Systems, a world leader in drug transporters, announces that a new U.S. patent issued on January 31st, protecting intellectual property around its P-glycoprotein (P-gp) knockdown cell line within the company’s CellPort Technologies brand.
-
Premier Research Expands Salt Lake City And Phoenix Testing Facilities Adding 50% Capacity
2/22/2012
Premier Research Group Limited announces the opening of new state-of-the-art clinical research facilities located in Phoenix and Salt Lake City, increasing their testing facilities capacity by 50%.
-
Roche’s xCELLigence Cardio Instrument Used To Detect Beating Rhythm And Proarrhythmic Effects Of Compounds In Stem Cell-Derived Cardiomyocytes
2/10/2012
In an effort to improve preclinical cardiotoxicity assays, reduce drug testing attrition rates, and ensure drug safety, collaborating scientists at the University Medical Center Utrecht in the Netherlands, and Bioscience Department of AstraZeneca R&D, Mölndal, Sweden, have tested Roche’s xCELLigence Cardio Instrument.
-
Oracle Health Sciences Institute, In Partnership With Oracle Labs, Announces First Round Of Research Projects
2/3/2012
Oracle Health Sciences Institute, in partnership with Oracle Labs, recently announced its first group of research projects, which includes initiatives with Brigham and Women’s Hospital and Harvard Medical School; the Coalition Against Major Diseases (CAMD) at the Critical Path Institute; the Human-Computer Interaction Lab (HCIL) at the University of Maryland.
-
Premier Research Names Dr. Colin Hayward As European Medical Director
1/18/2012
Premier Research Group announces the appointment of Dr. Colin Hayward to the position of European Medical Director. In this position, Dr. Hayward will be responsible for leading and developing the company’s European medical affairs and pharmacovigilance operations, critical components of the company’s global clinical development services offered to the biopharmaceutical industry.
-
Sitrof Technologies Introduces Argus Capture For Unstructured Content Management
12/28/2011
Sitrof Technologies, a leading provider of unstructured content management solutions for the life sciences industry, announced a new product recently, Sitrof Argus Capture powered by EMC InputAccel.
This website uses cookies to ensure you get the best experience on our website. Learn more